Company / Current Liabilities per Share
SELLAS Life Sciences Group, Inc. Current Liabilities per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.16
FY2024
5-year range
$0.16 / $2.43
FY2020-FY2024
Trend
-76.2%
vs FY2023
Sector context
#195 of 210
Health Care
What the data says
Among 210 Health Care companies, SELLAS Life Sciences Group, Inc. is in the top 7% for current liabilities per share. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.16 in FY2024 to $22.84 in FY2018.
Based on SEC 10-K filings.
0.16 in FY2024 with a 5-year CAGR of -40.4%.
Improved from $0.98 to $0.16 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -23.7%
- 5-Year CAGR
- -40.4%
- 10-Year CAGR
- -
Sector benchmark
-99.3% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 76.2% year-over-year.
- Ranks #195 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.16 | -76.2% |
| FY2023 | $0.65 | -33.0% |
| FY2022 | $0.98 | +179.3% |
| FY2021 | $0.35 | -85.6% |
| FY2020 | $2.43 | +17.5% |
| FY2019 | $2.07 | -90.9% |
| FY2018 | $22.84 | +117.6% |
| FY2017 | $10.50 | +1375.9% |
| FY2016 | $0.71 | +36.4% |
| FY2015 | $0.52 | +109.6% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026